Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
218.03
+2.32 (1.08%)
At close: Nov 13, 2026, 4:00 PM EST
218.05
+0.02 (0.01%)
After-hours: Nov 13, 2026, 7:48 PM EST
BDX Financials Overview
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Revenue Revenue Growth | 19,457 | 19,457 | 21,840 | 20,178 | 19,372 | 18,870 |
Revenue Growth | -10.91% | -10.91% | 8.24% | 4.16% | 2.66% | -1.36% |
Gross Profit Gross Profit Growth | 9,148 | 9,148 | 10,261 | 9,125 | 8,170 | 8,542 |
Operating Income Operating Income Growth | 3,048 | 3,048 | 3,662 | 2,847 | 2,130 | 2,564 |
Net Income Net Income Growth | 1,145 | 1,145 | 1,678 | 1,705 | 1,424 | 1,689 |
Earnings Per Share EPS Growth | 4.09 | 4.09 | 5.82 | 5.86 | 4.94 | 5.88 |
EPS Growth | -29.69% | -29.69% | -0.68% | 18.61% | -15.99% | -14.15% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
BioPharma Systems BioPharma Systems Growth | 2,437 | 2,437 | 2,324 | 2,273 | 2,229 | 2,001 |
Medical Essentials Medical Essentials Growth | 6,703 | 6,703 | 6,446 | - | - | - |
Connected Care Connected Care Growth | 4,744 | 4,745 | 4,556 | - | - | - |
Interventional Interventional Growth | 5,573 | 5,573 | 5,217 | - | - | - |
Revenue (Total) Revenue (Total) Growth | 19,457 | 19,457 | 21,840 | 20,178 | 19,372 | 18,870 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Cash & Investments Cash & Investments Growth | 733 | 733 | 649 | 2,162 | 1,424 | 1,014 |
Total Debt Total Debt Growth | 16,345 | 16,345 | 20,020 | 20,919 | 16,410 | 16,567 |
Net Cash (Debt) Net Cash Growth | -15,612 | -15,612 | -19,371 | -18,757 | -14,986 | -15,553 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -55.77 | -55.77 | -67.14 | -64.46 | -51.96 | -54.12 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 3,440 | 3,440 | 3,430 | 3,798 | 2,989 | 2,634 |
Capital Expenditures CapEx Growth | -672 | -672 | -760 | -725 | -874 | -973 |
Free Cash Flow Free Cash Flow Growth | 2,768 | 2,768 | 2,670 | 3,073 | 2,115 | 1,661 |
Free Cash Flow Growth | 3.67% | 3.67% | -13.11% | 45.30% | 27.33% | -51.90% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Gross Margin | 47.02% | 47.02% | 46.98% | 45.22% | 42.17% | 45.27% |
Operating Margin | 15.67% | 15.67% | 16.77% | 14.11% | 11.00% | 13.59% |
Pretax Margin | 9.27% | 9.27% | 8.61% | 9.94% | 8.58% | 9.45% |
Profit Margin | 5.88% | 5.88% | 7.68% | 8.45% | 7.35% | 8.95% |
FCF Margin | 14.23% | 14.23% | 12.22% | 15.23% | 10.92% | 8.80% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 4.240 | - | 4.160 | 3.800 | 3.640 | 3.480 |
Dividend Per Share Growth | 0.96% | - | 9.47% | 4.40% | 4.60% | 4.82% |
Dividend Yield | 1.95% | - | 2.21% | 1.58% | 1.41% | 1.55% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
PE Ratio | 53.28 | 42.58 | 31.97 | 40.87 | 52.67 | 37.63 |
Forward PE | 16.50 | 13.52 | 12.94 | 17.29 | 19.65 | 19.05 |
P/FCF Ratio | 21.46 | 17.61 | 20.09 | 22.68 | 35.46 | 38.26 |
PS Ratio | 3.05 | 2.51 | 2.46 | 3.45 | 3.87 | 3.37 |